Product correctly added to cart.

discount label
Duocarmycin DM
View 3D

Biosynth logo

Duocarmycin DM

CAS: 1116745-06-2

Ref. 3D-RUB74506

1mg
801.00 €
2mg
1,160.00 €
5mg
1,739.00 €
10mg
2,551.00 €
25mg
5,217.00 €
Estimated delivery in United States, on Wednesday 15 Jan 2025

Product Information

Name:
Duocarmycin DM
Description:

Duocarmycin DM is an anticancer drug that selectively targets cancer cells and induces apoptosis. It works by binding to the minor groove of DNA and forming a covalent bond with adenine, which leads to DNA damage and ultimately cell death. Duocarmycin DM has been shown to be effective against a variety of human cancer cell lines, including those resistant to other chemotherapeutic agents. This drug also inhibits kinases involved in tumor growth and angiogenesis, making it a promising candidate for cancer therapy. Duocarmycin DM has been studied as an analog to artesunate and chloroquine in Chinese patients with cancer. Inhibitors of this drug have been identified in urine samples from patients receiving treatment, indicating its potential as a therapeutic agent for the treatment of cancer.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
464 g/mol
Formula:
C26H26ClN3O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-RUB74506 Duocarmycin DM

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".